Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DE LA LYS : revenue, balance sheet and financial ratios

SELARL PHARMACIE DE LA LYS is a French company founded 3 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-VENANT (62350), this company of category PME shows in 2025 a net income positive of 69 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DE LA LYS (SIREN 951153287)
Indicator 2025 2024
Revenue N/C N/C
Net income 68 510 € -7 173 €
EBITDA N/C N/C
Net margin N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE DE LA LYS generates positive net income of 69 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

68 510 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 771%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

770.881%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

10.13%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

88.4%

Solvency indicators evolution
SELARL PHARMACIE DE LA LYS

Sector positioning

Debt ratio
770.88 2025
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Watch

In 2025, the debt ratio of SELARL PHARMACIE DE LA LYS (770.88) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
10.13% 2025
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch

In 2025, the financial autonomy of SELARL PHARMACIE DE LA LYS (10.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 223.17. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

223.167

Liquidity indicators evolution
SELARL PHARMACIE DE LA LYS

Sector positioning

Liquidity ratio
223.17 2025
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good +10 pts over 2 years

In 2025, the liquidity ratio of SELARL PHARMACIE DE LA LYS (223.17) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMACIE DE LA LYS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of SELARL PHARMACIE DE LA LYS is estimated at 1 088 289 € (range 738 518€ - 1 707 676€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
738k€ 1088k€ 1707k€
1 088 289 € Range: 738 518€ - 1 707 676€
NAF 5 année 2025

Valuation method used

Net Income Multiple
68 510 € × 15.9x = 1 088 289 €
Range: 738 518€ - 1 707 676€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DE LA LYS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DE LA LYS

What is the revenue of SELARL PHARMACIE DE LA LYS ?

The revenue of SELARL PHARMACIE DE LA LYS is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DE LA LYS profitable?

Yes, SELARL PHARMACIE DE LA LYS generated a net profit of 69 k€ in 2025.

Where is the headquarters of SELARL PHARMACIE DE LA LYS ?

The headquarters of SELARL PHARMACIE DE LA LYS is located in SAINT-VENANT (62350), in the department Pas-de-Calais.

Where to find the tax return of SELARL PHARMACIE DE LA LYS ?

The tax return of SELARL PHARMACIE DE LA LYS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DE LA LYS operate?

SELARL PHARMACIE DE LA LYS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.